HATFIELD, PA — Biolyst Scientific has appointed Jay Hexamer as its new Chief Executive Officer, effective immediately, to drive growth and innovation in the company’s next phase of development.

With more than 30 years of experience in the scientific, healthcare, and life sciences industries, Hexamer brings deep expertise in strategic leadership, operational excellence, and growth management.

--(BUSINESS WIRE)--Biolyst Scientific, a leading provider of innovative solutions in the life sciences and clinical laboratory markets, is pleased to announce the appointment of Jay Hexamer as its ...

Histone modification is an epigenetic mechanism that regulates gene expression by altering chromatin structure and DNA accessibility for transcription. Histone modification is regulated by various ...

Biolyst Scientific, a leading provider of innovative solutions in the life sciences and clinical laboratory markets, is pleased to announce the appointment of Jay Hexamer as its new Chief Executive ...

Department of Plant Sciences, University of Cambridge, U.K.

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Huntington’s disease (HD) is a debilitating ...

The cadherin family, which includes T-cadherin, plays a significant role in angiogenesis, a critical process involved in tumor growth, metastasis, and recurrence. T-cadherin is extensively expressed ...